Old and new applications of non-anticoagulant heparin (original) (raw)

Recent advances in search of oral heparin therapeutics

Dr. Shivani Rai Paliwal

Medicinal Research Reviews, 2012

View PDFchevron_right

Therapeutic uses of heparin beyond its traditional role as an anticoagulant

S. Kilfeather

Trends in Pharmacological Sciences, 1995

View PDFchevron_right

The Anticoagulant and Nonanticoagulant Properties of Heparin

Gerry Nicolaes

Thrombosis and Haemostasis

View PDFchevron_right

Non-Anticoagulant Heparins as Heparanase Inhibitors

annamaria naggi

Advances in Experimental Medicine and Biology

View PDFchevron_right

Evaluation of the in vitro and in vivo therapeutic equivalence of two pharmaceutically equivalent heparin products

Yasser Bustanji

2011

View PDFchevron_right

Heparin derivatives for the targeting of multiple activities in the inflammatory response

annamaria naggi

Carbohydrate Polymers, 2015

View PDFchevron_right

Beyond anticoagulant: Heparin as a potential anti-cancer agent

Ravi Lokwani

Journal of Biochemistry, Microbiology and Biotechnology, 2014

View PDFchevron_right

Heparin and Derivatives for Advanced Cell Therapies

Eva Rohde

International Journal of Molecular Sciences, 2021

View PDFchevron_right

Antimetastatic activities of heparins and modified heparins. Experimental evidence

Lubor Borsig

Thrombosis Research, 2010

View PDFchevron_right

Non-Anticoagulant Low Molecular Weight Heparins for Pharmaceutical Applications

Zhenqing Zhang

Journal of Medicinal Chemistry, 2019

View PDFchevron_right

Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties

John Castellot

Glycobiology, 1996

View PDFchevron_right

Preclinical studies on a low molecular weight heparin

Ahmad ridhani ahsan

Thrombosis Research, 1996

View PDFchevron_right

Non-Anticoagulant Heparins and Inhibition of Cancer

Israel Vlodavsky

Pathophysiology of Haemostasis and Thrombosis, 2007

View PDFchevron_right

Heparin/heparan sulphate-based drugs

Ricardo Mancera

Drug Discovery Today, 2010

View PDFchevron_right

Unfractionated and Low-Molecular-Weight Heparins, Basic Mechanism of Action and Pharmacology

Maria Florian

Seminars in Cardiothoracic and Vascular Anesthesia, 2003

View PDFchevron_right

Heparin Mimetics: Their Therapeutic Potential

Deirdre Coombe

Pharmaceuticals (Basel, Switzerland), 2017

View PDFchevron_right

Development of new heparin-like compounds and other antithrombotic drugs and their interaction with vascular endothelial cells

Ricardo Fulgencio

Brazilian Journal of Medical and Biological Research, 2001

View PDFchevron_right

2 Mechanisms of action of low molecular weight heparins and heparinoids

Frederick Ofosu

Baillière's Clinical Haematology, 1990

View PDFchevron_right

Chemical composition, particle size range, and biological activity of some low molecular weight heparin derivatives

Paul Rochon

Journal of Pharmaceutical Sciences, 1990

View PDFchevron_right

Heparins and Heparinoids: Occurrence, Structure and Mechanism of Antithrombotic and Hemorrhagic Activities

Helena Nader

Current Pharmaceutical Design, 2004

View PDFchevron_right

Pharmacokinetic, hemostatic and anticancer properties of a low-anticoagulant bovine heparin

Paulo Mourao

TH Open

View PDFchevron_right

Antiangiogenic heparin-derived heparan sulfate mimics

annamaria naggi

Pure and Applied Chemistry, 2000

View PDFchevron_right

Homogeneous low-molecular-weight heparins with reversible anticoagulant activity

truong pham

Nature Chemical Biology, 2014

View PDFchevron_right

N' alkylamine low molecular mass heparins (LMM-heparin-tyramine and LMM-heparin-tyramine-fitc) exhibit long lasting anticoagulant effects

Job Harenberg

Thrombosis Research, 1995

View PDFchevron_right

Heparin: Powerful and Instantaneously acting Anticoagulant

PharmaTutor Edu Labs

View PDFchevron_right

Supersulfated" heparin fragments, a new type of low-molecular weight heparin. Physico-chemical and pharmacological properties

Giangiacomo Torri

Biochemical Pharmacology

View PDFchevron_right

A non-hemorrhagic hybrid heparin/heparan sulfate with anticoagulant potential

Ashley J. Hughes

Carbohydrate Polymers, 2014

View PDFchevron_right

Antimetastatic effects associated with anticoagulant properties of heparin and chemically modified heparin species in a mouse mammary tumor model

Gabriel Bertolesi

Oncology Reports, 1996

View PDFchevron_right

Glycosaminoglycan backbone is not required for the modulation of hemostasis: Effect of different heparin derivatives and non-glycosaminoglycan analogs

Ivarne Tersariol, Helena Nader, Edvaldo Trindade

Matrix Biology, 2012

View PDFchevron_right

The heparins and cancer: review of clinical trials and biological properties

Fernando Porro, Roberto Castelli

Vascular Medicine, 2004

View PDFchevron_right

Heparins: Clinical use and laboratory monitoring

Maureane Hoffman

Laboratory Medicine, 2010

View PDFchevron_right

Lipolytic and anticoagulant activities of a low molecular weight fragment of heparin

Peter Nilsson-Ehle

European Journal of Clinical Investigation, 1985

View PDFchevron_right

Treatment of concanavalin A-induced hepatitis in mice with low molecular weight heparin

rami hershkoviz

Journal of Hepatology, 1999

View PDFchevron_right